# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-014204
Filing Date
2021-03-18
Accepted
2021-03-18 17:24:54
Documents
5
Period of Report
2021-04-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | acet-def14a_20210427.htm | DEF 14A | 1121431
2 | GRAPHIC | gu3c32wcjg3v000002.jpg | GRAPHIC | 14870
3 | GRAPHIC | gu3c32wcjg3v000001.jpg | GRAPHIC | 14870
4 | GRAPHIC | gu3c32wcjg3v000003.jpg | GRAPHIC | 388255
5 | GRAPHIC | gu3c32wcjg3v000004.jpg | GRAPHIC | 322127
| Complete submission text file | 0001564590-21-014204.txt |  | 2141766

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38359 | Film No.: 21755501
SIC: 2834 Pharmaceutical Preparations